EP Patent

EP2437723A1 — Omega-3 oil containing ophthalmic emulsions

Assigned to Johnson and Johnson Surgical Vision Inc · Expires 2012-04-11 · 14y expired

What this patent protects

Disclosed herein are non-irritating ophthalmic emulsion compositions useful for treating ocular disorders including dry eye. More specifically, the ophthalmic compositions disclosed herein combine a high HLB surfactant and a low HLB surfactant together with an omega-3 fatty acid-…

USPTO Abstract

Disclosed herein are non-irritating ophthalmic emulsion compositions useful for treating ocular disorders including dry eye. More specifically, the ophthalmic compositions disclosed herein combine a high HLB surfactant and a low HLB surfactant together with an omega-3 fatty acid-containing oil having non-polar aliphatic side chains to form a therapeutic non-irritating eye drop.

Drugs covered by this patent

Patent Metadata

Patent number
EP2437723A1
Jurisdiction
EP
Classification
—
Expires
2012-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Johnson and Johnson Surgical Vision Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.